The US Food and Drug Administration on Tuesday night posted a corrected list of more than 3,000 New England Compounding Company customers that purchased products other than the suspected lots of injectable steroids blamed for a nationwide fungal meningitis outbreak.

Among them were 215 Massachusetts doctors and health centers, including most of the state’s hospitals. All received products shipped on or after May 21, the date when the first batch of suspect steroids were produced at the Framingham pharmacy.